Home
Conditions
Neoplasms, Nerve Tissue

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,287 public trials 1,279 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Recruiting

Robot-Assisted Neurovascular Intervention

NCT06752096

Conditions: Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +15 more
Locations: Severence Hospital, Yonsei University College of Medicine Seoul, Korea, South Korea

View Trial Details

Recruiting

Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy

NCT03144167

Conditions: Astrocytoma, Chemotherapy, Glioblastoma, +9 more
Locations: CHU Amiens Picardie Amiens, Picardie, France

View Trial Details

Recruiting

Control Cohort CTRL COH

NCT05370079

Conditions: Amyotrophic Lateral Sclerosis, Astrocytoma, Basal Ganglia Diseases, +25 more
Locations: Hospices Civils de Lyon Bron, France

View Trial Details

Recruiting

Sample Collection for Ongoing Research and Product Evaluation Study

NCT07318051

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +61 more
Locations: Natera, Inc. Austin, Texas, United States

View Trial Details

Recruiting

Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs

NCT06356467

Conditions: GEP-NET, Gastro-enteropancreatic neuroendocrine tumor, Neoplasms, +5 more
Locations: IRCCS OSpedale San Raffaele Milan, Italy

View Trial Details

Recruiting

Institutional Registry of Rare Diseases

NCT06573723

Conditions: Abnormalities, Multiple, Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, +144 more
Locations: Hospital Italiano de Buenos Aires Buenos Aires, Argentina

View Trial Details

Recruiting

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

NCT06887348

Conditions: Adenocarcinoma, Advanced Solid Tumor, Carcinoma, +20 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Tasman Oncology Research Southport, Queensland, Australia

View Trial Details

Recruiting

A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma

NCT03829254

Conditions: Advanced Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Cambridge University Hospitals NHS Foundation Trust (Addenbrookes Hospital) Cambridge, United Kingdom

Edinburgh Cancer Centre, Western General Hospital Edinburgh, United Kingdom

The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom

University College London Hospital London, United Kingdom

View Trial Details

Recruiting

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

NCT05465954

Conditions: Astrocytoma, Glioblastoma, Glioma, +11 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Recruiting

A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

NCT07334301

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations: Sydney Children's Hospital (SCH) Sydney, Australia

St. Anna Children´s Hospital Vienna, Austria

Cliniques Universitaires Saint-Luc (CUSL) Brussels, Belgium

Starship Children's Hospital (SSH) Auckland, New Zealand

View all 23 locations

View Trial Details

Neoplasms, Nerve Tissue

Neoplasms, Nerve Tissue trial results

Related conditions